Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. [electronic resource]
Producer: 20070612Description: 170-7 p. digitalISSN:- 1532-8414
- Arrhythmias, Cardiac -- etiology
- Dose-Response Relationship, Drug
- Double-Blind Method
- Erythrocytes -- metabolism
- Exercise Tolerance -- drug effects
- Female
- Heart Failure -- blood
- Heart Function Tests -- drug effects
- Homeostasis -- drug effects
- Humans
- Magnesium -- blood
- Magnesium Deficiency -- blood
- Male
- Middle Aged
- Mineralocorticoid Receptor Antagonists -- therapeutic use
- Potassium -- blood
- Spironolactone -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.